Learn More
BACKGROUND A few and partial data are available on psychosocial morbidity among cancer patients in Mediterranean countries. As a part of a more general investigation (Southern European Psycho-Oncology Study-SEPOS), the rate of psychosocial morbidity and its correlation with clinical and cultural variables were examined in cancer patients in Italy, Portugal(More)
Physician-patient communication is a critical factor for comprehensive care in oncology. Although a number of studies have been carried out in Northern Europe and the US on this subject, no data are available in Southern European countries. As a part of a multicenter Southern European Psycho-Oncology study (SEPOS), the present investigation was conducted to(More)
Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer(More)
BACKGROUND Cancer is a complex health problem requiring multidisciplinary care. There are clinical guidelines available in order to improve the process and outcomes of cancer care within Europe. However, strategic action is still needed in many European Union (EU) Member States to develop or improve national cancer control plans (NCCPs), which play a key(More)
OBJECTIVE This study addresses the meanings women with breast cancer attach to their illness within a cognitive-developmental framework. The aim of the present study was twofold: (i) to identify the content of women's meanings in five domains of breast cancer representation (identity, causes, consequences, timeline and controllability), and (ii) to verify(More)
BACKGROUND Although hopelessness has been studied in cancer, no data are available in non-English-speaking countries. OBJECTIVE The authors sought to amass data from Southern European countries (Italy, Portugal, Spain, and Switzerland) in order to fill this void. METHOD A group of 312 cancer patients completed the Mini-MAC Hopelessness subscale, the(More)
The International Psycho-oncology Society (IPOS) has just celebrated its 30th anniversary. The growth of psychosocial oncology has been exponential, and this relatively new field is becoming a core service that focuses on prevention, reducing the burden of cancer, and enhancing the quality of life from time of diagnosis, through treatment, survivorship, and(More)
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) thanks to contribution of 64 ESMO-appointed and 32 ASCO-appointed authors. First published in 2004 and updated in 2010, the GC edition 2016 answers to the need for updated recommendations(More)
The International Psycho-Oncology Society (IPOS) Human Rights Task Force has been working since 2008 to raise awareness and support, for the relevance of psychosocial cancer care as a human rights issue. In 2014 the "Lisbon Declaration: Psychosocial Cancer Care as a Universal Human Right" was fully endorsed by IPOS. Subsequently, the IPOS Standard on(More)
  • Luzia Travado
  • 2006
The last two decades have witnessed a dramatic growth in interest in the assessment of quality of life (QoL) in both oncology research and practice [1–3]. The availability of reliable, cancer-specific instruments for use with cancer patients (e.g., EORTC QLQ-C30, FACT), the changing attitude towards a more biopsychosocial oriented model of clinical(More)